Skip to main content

CORRECTION article

Front. Immunol., 31 May 2021
Sec. Autoimmune and Autoinflammatory Disorders
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.710831

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature

This article is a correction to:

  1. Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature

    1. Read original article
Tiina Kelkka,,,*Tiina Kelkka1,2,3,4*Paula Savola,,,&#x;Paula Savola1,2,3,4†Dipabarna Bhattacharya,,,&#x;Dipabarna Bhattacharya1,2,3,4†Jani Huuhtanen,,,&#x;Jani Huuhtanen1,2,3,4†Tapio LnnbergTapio Lönnberg5Matti Kankainen,,Matti Kankainen1,2,4Kirsi PaalanenKirsi Paalanen6Mikko Tyster,,,Mikko Tyster1,2,3,4Maija LepistMaija Lepistö7Pekka EllonenPekka Ellonen7Johannes SmolanderJohannes Smolander5Samuli EldforsSamuli Eldfors7Bhagwan Yadav,,,Bhagwan Yadav1,2,3,4Sofia KhanSofia Khan5Riitta KoivuniemiRiitta Koivuniemi8Christopher SjwallChristopher Sjöwall9Laura L. Elo,Laura L. Elo5,10Harri LhdesmkiHarri Lähdesmäki11Yuka MaedaYuka Maeda12Hiroyoshi NishikawaHiroyoshi Nishikawa12Marjatta Leirisalo-RepoMarjatta Leirisalo-Repo8Tuulikki Sokka-Isler,Tuulikki Sokka-Isler6,13Satu Mustjoki,,,*Satu Mustjoki1,2,3,4*
  • 1Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland
  • 2Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
  • 3Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
  • 4Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
  • 5Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
  • 6Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland
  • 7Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland
  • 8Rheumatology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland
  • 9Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden
  • 10Institute of Biomedicine, University of Turku, Turku, Finland
  • 11Department of Computer Science, Aalto University School of Science, Espoo, Finland
  • 12Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Japan
  • 13University of Eastern Finland, Faculty of Health Sciences, Kuopio, Finland

A Corrigendum on
Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature

By Kelkka T, Savola P, Bhattacharya D, Huuhtanen J, Lönnberg T, Kankainen M, Paalanen K, Tyster M, Lepistö M, Ellonen P, Smolander J, Eldfors S, Yadav B, Khan S, Koivuniemi R, Sjöwall C, Elo LL, Lähdesmäki H, Maeda Y, Nishikawa H, Leirisalo-Repo M, Sokka-Isler T and Mustjoki S (2020) Front. Immunol. 11:578848. doi: 10.3389/fimmu.2020.578848

An author name was incorrectly spelled as Hiroyashi Nishikawa. The correct spelling is Hiroyoshi Nishikawa.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: rheumatoid arthritis, seronegative, ACPA-negative, CD8+ lymphocyte, T cell receptor, somatic mutation

Citation: Kelkka T, Savola P, Bhattacharya D, Huuhtanen J, Lönnberg T, Kankainen M, Paalanen K, Tyster M, Lepistö M, Ellonen P, Smolander J, Eldfors S, Yadav B, Khan S, Koivuniemi R, Sjöwall C, Elo LL, Lähdesmäki H, Maeda Y, Nishikawa H, Leirisalo-Repo M, Sokka-Isler T and Mustjoki S (2021) Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature. Front. Immunol. 12:710831. doi: 10.3389/fimmu.2021.710831

Received: 17 May 2021; Accepted: 19 May 2021;
Published: 31 May 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Kelkka, Savola, Bhattacharya, Huuhtanen, Lönnberg, Kankainen, Paalanen, Tyster, Lepistö, Ellonen, Smolander, Eldfors, Yadav, Khan, Koivuniemi, Sjöwall, Elo, Lähdesmäki, Maeda, Nishikawa, Leirisalo-Repo, Sokka-Isler and Mustjoki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Satu Mustjoki, satu.mustjoki@helsinki.fi; Tiina Kelkka, tiina.kelkka@helsinki.fi

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.